Kim et al. [21] found significantly reduced levels of phosphorylated cofilin in the frontal cortex of patients with AD compared to healthy controls, suggesting elevated cofilin activity [21], which appears to contradict the findings of Heredia and colleagues [17]. This evidence concerns the gene CFL1 and Alzheimer disease.